Home > Journals > Medicine > Hépato-Gastro > summary
      Advanced search    Shopping cart    French version 
Latest books
All journals
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
How can I publish?
Help for advertisers
Foreign rights
Book sales agents


Texte intégral de l'article
Printable version

Role of prostaglandins in colorectal cancer

Hépato-Gastro. Volume 16, Number 2, 137-45, mars-avril 2009, Mini-revue

Résumé   Article gratuit  

Author(s) : Rachid Zagani, Nadim Hamzaoui, Dominique Lamarque

Summary : Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Classical non-steroidal anti-inflammatory drugs and coxibs, selective inhibitors of cyclo-oxygenase-2 (Cox2), were highly effective in inhibiting tumor growth and preventing CRC in humans and in mice models. Recent reports show that one of the bioactive products of Cox2, prostaglandin E2, activate, after binding to its receptors, multiple intracellular pathways involved in colorectal tumorigenesis. The findings reviewed here reveal important crosstalks between these pathways, which could provide opportunities for the development of new drugs for the treatment and prevention of CRC.

Keywords : colorectal cancer, prostaglandin


About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]